Active Ingredient(s): Ferumoxytol
FDA Approved: * June 30, 2009
Pharm Company: * AMAG PHARMS INC
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Feraheme Overview

FeO.Fe2O3 Molar mass 231.533 g/mol Appearance solid black powder Density 5 g/cm3 Melting point 1,597°C (2,907°F; 1,870K) Boiling point 2,623[1]°C (4,753°F; 2,896K) Refractive index (nD) 2.42[2] Hazards NFPA 704 (firediamond) 0 0 1OX Thermochemistry Std enthalpy offormation (ΔfH298) -1120.89kJ...

Read more Feraheme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iron(II,III)_oxide

Recent Feraheme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: eq 510mg iron/17ml (eq 30mg iron/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Feraheme: (1 result)

Sorted by National Drug Code
  • 59338-775 Feraheme 510 mg/17ml Intravenous Injection by Amag Pharmaceuticals, Inc.

Other drugs which contain Ferumoxytol or a similar ingredient: (1 result)